课题基金 / 基金详情

Maximizing CD8 T Cells for Protection

Maximizing CD8 T Cells for Protection
最大限度地发挥 CD8 T 细胞的保护作用
批准号:
7849270
负责人:
DAVID MASOPUST
金额:
$226.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2014-06-30

项目摘要

项目成果

DAVID MASOPUST的其他基金

相关文献

中文摘要
翻译
描述(由申请人提供)
英文摘要
DESCRIPTION (Provided by the applicant) Abstract: HIV has claimed >25 million lives. Two decades of research, but no vaccine. Theoretically, generation of CD8 T cell immunity may succeed where traditional, neutralizing antibody-dependent, vaccines have failed. But, nascent efforts have consistently failed to prevent chronic SIV infection in monkeys following a stringent challenge, and the first human HIV CD8 T cell vaccine trial was a complete failure. Why? Is a preventative CD8 T cell vaccine impossible, as many now suggest? We hypothesize that past efforts have been crippled by a safety-first approach and relative ignorance of the importance of memory CD8 T cell quantity, quality, and location to protection. Current approaches are largely refinements of past failures. A bolder approach is long overdue, at least in animal models where safety requirements are less stringent. What could SIV specific memory CD8 T cells accomplish if they were 500-fold more plentiful than what is established by current vaccination strategies? What if these cells were preferentially located at common portals of viral entry and destroyed infected host tissue quickly upon contact? If a vaccine converted most CD8 T cells into HIV or SIV specific memory cells, could they fully protect the host and eliminate the infection completely? Or are CD8 T cells incapable of fulfilling this goal, even under ideal scenarios? This proposal will answer these essential questions. Moreover, it will test the limits of memory CD8 T cell generation, and define CD8 T cell correlates of protection. If successful, this study may demonstrate that a preventative HIV vaccine is theoretically possible. Public Health Relevance: This proposal will investigate how memory CD8 T cells are generated via vaccination, and determine the relationship between memory CD8 T cell quantity, quality, and location and their contribution to protection from infection. These findings will have direct relevance to vaccination and to establishing correlates of CD8 T cell dependent protective immunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Resident Memory T Cells
  • 批准号:
    10242062
  • 项目类别:
  • 资助金额:
    $60.46万
  • 财政年份:
    2020
  • 负责人:
    DAVID MASOPUST
  • 依托单位:
Resident Memory T Cells
  • 批准号:
    10455752
  • 项目类别:
  • 资助金额:
    $60.46万
  • 财政年份:
    2020
  • 负责人:
    DAVID MASOPUST
  • 依托单位:
Resident Memory T Cells
  • 批准号:
    10667482
  • 项目类别:
  • 资助金额:
    $60.46万
  • 财政年份:
    2020
  • 负责人:
    DAVID MASOPUST
  • 依托单位:
Repurposing TRM for tumor immunotherapy
  • 批准号:
    10549817
  • 项目类别:
  • 资助金额:
    $48.04万
  • 财政年份:
    2019
  • 负责人:
    DAVID MASOPUST
  • 依托单位: